Prophylactic Intra-Uterine β-Cyclodextrin Administration during Intra-Uterine Ureaplasma parvum Infection Partly Prevents Liver Inflammation without Interfering with the Enterohepatic Circulation of the Fetal Sheep
den Dulk, M.
van Heugten, C.
Beeton, Michael L.
MetadataShow full item record
Chorioamnionitis can lead to inflammation and injury of the liver and gut, thereby predisposing patients to adverse outcomes such as necrotizing enterocolitis (NEC). In addition, intestinal bile acids (BAs) accumulation is causally linked to NEC development. Plant sterols are a promising intervention to prevent NEC development, considering their anti-inflammatory properties in the liver. Therefore, we investigated whether an intra-amniotic (IA) Ureaplasma parvum (UP) infection affected the liver and enterohepatic circulation (EHC) and evaluated whether an IA administered plant sterol mixture dissolved in β-cyclodextrin exerted prophylactic effects. An ovine chorioamnionitis model was used in which liver inflammation and the EHC were assessed following IA UP exposure in the presence or absence of IA prophylactic plant sterols (a mixture of β-sitosterol and campesterol dissolved in β-cyclodextrin (carrier)) or carrier alone. IA UP exposure caused an inflammatory reaction in the liver, histologically seen as clustered and conflated hepatic erythropoiesis in the parenchyma, which was partially prevented by IA administration of sterol + β-cyclodextrin, or β-cyclodextrin alone. In addition, IA administration of β-cyclodextrin prior to UP caused changes in the expression of several hepatic BAs transporters, without causing alterations in other aspects of the EHC. Thereby, the addition of plant sterols to the carrier β-cyclodextrin did not have additional effects.
Heymans, C., Heij, L.R., Lenaerts, K., den Dulk, M., Hadfoune, M., van Heugten, C., Spiller, O.B., Beeton, M.L., Stock, S.J., Jobe, A.H. and Payne, M.S. (2020) 'Prophylactic Intra-Uterine β-Cyclodextrin Administration during Intra-Uterine Ureaplasma parvum Infection Partly Prevents Liver Inflammation without Interfering with the Enterohepatic Circulation of the Fetal Sheep', Nutrients, 12(5), p.1312.
Article published in Nutrients on 5 May 2020, available open access at: https://doi.org/10.3390/nu12051312.
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
This work was financially supported by Kinderonderzoekfonds Limburg (Health Foundation Limburg) (T.G.A.M.W.).
Showing items related by title, author, subject and abstract.
Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in non-alcoholic fatty liver disease (NAFLD) Pugh, Christopher J. A.; Sprung, Victoria; Jones, Helen; Richardson, Paul; Shojaee-Morade, Faribra; Umpleby, A. Margot; Green, Daniel J.; Cable, N. Timothy; Trennel, Michael I.; Kemp, Graham J.; Cuthbertson, Daniel J. (Nature Publishing Group, 2016-07-21)AIMS: Supervised exercise reduces liver fat and improves endothelial function, a surrogate of cardiovascular disease risk, in non-alcoholic fatty liver disease (NAFLD). We hypothesised that after a 16-week supervised ...
Dissociation between exercise-induced reduction in liver fat and changes in hepatic and peripheral glucose homoeostasis in obese patients with non-alcoholic fatty liver disease Cuthbertson, Daniel; Shojaee-Moradie, Fariba; Sprung, Victoria; Jones, Helen; Pugh, Christopher J. A.; Richardson, Paul; Kemp, Graham; Barrett, Mark; Jackson, Nicola; Thomas, Louise; Bell, Jimmy; Umpleby, Margot (Portland Press, 2015-12-09)Non-alcoholic fatty liver disease (NAFLD) is associated with multi-organ (hepatic, skeletal muscle, adipose tissue) insulin resistance (IR). Exercise is an effective treatment for lowering liver fat but its effect on IR ...
Pugh, Christopher J. A.; Sprung, Victoria S.; Kemp, Graham J.; Richardson, Paul; Shojaee-Moradie, Fariba; Umpleby, A. Margot; Green, Daniel J.; Cable, N. Timothy; Jones, Helen; Cuthbertson, Daniel J. (American Physiological Society, 2014-11-01)Nonalcoholic fatty liver disease (NAFLD) is an independent risk factor for cardiovascular disease (CVD). Endothelial dysfunction is an early manifestation of atherosclerosis and an important prognostic marker for future ...